Filtered By:
Specialty: Pharmaceuticals

This page shows you your search results in order of date. This is page number 11.

Order by Relevance | Date

Total 890 results found since Jan 2013.

Portable MRI Can Detect Infarcts in Patients With Ischemic Stroke
THURSDAY, April 21, 2022 -- Low-field portable magnetic resonance imaging (pMRI) acquired at low magnetic field strength can detect infarcts in patients with ischemic stroke, according to a study published online April 20 in Science...
Source: Drugs.com - Pharma News - April 21, 2022 Category: Pharmaceuticals Source Type: news

Online Program Aids Behavior Changes in Stroke Survivors
WEDNESDAY, April 20, 2022 -- The online " Prevent 2nd Stroke " (P2S) behavior change intervention improves stroke survivors ' self-reported global ratings of health-related quality of life (HRQoL) at six months, according to a study published online...
Source: Drugs.com - Pharma News - April 20, 2022 Category: Pharmaceuticals Source Type: news

Nearby Greenspace Tied to Lower Stroke Risk
WEDNESDAY, April 20, 2022 -- Living in areas with greater greenspace is tied to a lower risk for stroke, according to a study published online April 18 in the Journal of Patient-Centered Research and Reviews. Heloise Cheruvalath, from Smith College...
Source: Drugs.com - Pharma News - April 20, 2022 Category: Pharmaceuticals Source Type: news

Sitting Tai Chi Program Benefits Subacute Stroke Survivors
THURSDAY, April 7, 2022 -- A tailored 12-week sitting tai chi program is beneficial for the recovery of subacute stroke survivors, according to a study published online April 7 in Stroke. Jie Zhao, Ph.D., from the Yunnan University of Traditional...
Source: Drugs.com - Pharma News - April 7, 2022 Category: Pharmaceuticals Source Type: news

A-Fib Detected in Nearly Three in 10 Cryptogenic Stroke Patients
TUESDAY, April 5, 2022 -- Almost one in three patients surviving a stroke of unknown cause have atrial fibrillation (AF) detectable using continuous cardiac monitoring, according to a study presented at the annual meeting of the European Heart...
Source: Drugs.com - Pharma News - April 5, 2022 Category: Pharmaceuticals Source Type: news

Data from New VOYAGER PAD Analyses at ACC.22 Reinforce Benefit of XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Peripheral Artery Disease (PAD) and Various Co-Morbid Conditions
RARITAN, N.J., April 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from new analyses from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefit of the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) in reducing severe vascular events in patients with PAD after lower-extremity revascularization (LER), a procedure that restores blood flow to the legs. Data from the two analyses demonstrate the role that the XARELTO® vascular dose plays in PAD patients with and without chronic kidney disease (CKD) and in PAD patients with and ...
Source: Johnson and Johnson - April 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

New-Onset Cardiovascular Complications Common After Stroke
THURSDAY, March 31, 2022 -- New-onset cardiovascular complications diagnosed after ischemic stroke are common and are associated with worse long-term prognosis, according to a study published online March 31 in Stroke. Benjamin J.R. Buckley, Ph.D.,...
Source: Drugs.com - Pharma News - March 31, 2022 Category: Pharmaceuticals Source Type: news

New Janssen Initiative Aims to Advance Equitable Care and Address Hidden Threat of Amputation Related to Peripheral Artery Disease (PAD)
TITUSVILLE, N.J., March 31, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the launch of Save Legs. Change Lives.™ Spot Peripheral Artery Disease Now, a multi-year initiative aimed at creating urgency and action to address the hidden threat of peripheral artery disease (PAD)-related amputation, with an initial focus on reaching Black Americans, who are more than twice as likely to be impacted by PAD.1 Janssen has joined forces with leading professional associations, healthcare systems and community organizations to advance equitable care for individuals and communities placed at an...
Source: Johnson and Johnson - March 31, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

2019 to 2020 Saw Risk-Linked Deaths From Heart Disease, Stroke Up
TUESDAY, March 29, 2022 -- From 2019 to 2020, there was an increase in risk-associated deaths from heart disease and stroke, according to a research letter published online March 23 in JAMA Network Open. Stephen Sidney, M.D., from Kaiser Permanente...
Source: Drugs.com - Pharma News - March 29, 2022 Category: Pharmaceuticals Source Type: news

Risk for Ischemic Stroke Up With Antidopaminergic Antiemetic Use
TUESDAY, March 29, 2022 -- The risk for ischemic stroke is increased in association with the use of antidopaminergic antiemetics (ADAs), according to a study published online March 23 in The BMJ. Anne B énard-Laribière, from the University of...
Source: Drugs.com - Pharma News - March 29, 2022 Category: Pharmaceuticals Source Type: news

Videogaming Rehabilitation Studied in Stroke Patients
MONDAY, March 28, 2022 -- For adults after stroke, self-managed motor-gaming with behavioral telerehabilitation is as effective as in-clinic Constraint-Induced Movement (CI) therapy for improving motor function and everyday use of the arm, according...
Source: Drugs.com - Pharma News - March 28, 2022 Category: Pharmaceuticals Source Type: news

ACC: Use of Salt Substitute to Prevent Stroke Is Cost-Saving
MONDAY, March 28, 2022 -- Among individuals with prior stroke or uncontrolled high blood pressure, replacing regular salt with salt substitute is a cost-saving intervention for reducing the risk for stroke, according to a study published online...
Source: Drugs.com - Pharma News - March 28, 2022 Category: Pharmaceuticals Source Type: news

Hypertriglyceridemia Linked to Vascular Risk After Stroke
WEDNESDAY, March 23, 2022 -- For patients with stroke of atherothrombotic origin, hypertriglyceridemia is associated with residual vascular risk, even for those on statin therapy, according to a study published online March 16 in Neurology. Takao...
Source: Drugs.com - Pharma News - March 23, 2022 Category: Pharmaceuticals Source Type: news

Meds, Exercise Recommended for Stroke Prevention After sICAS
TUESDAY, March 22, 2022 -- For patients with symptomatic intracranial atherosclerotic arterial stenosis (sICAS), initial treatment should comprise medications and exercise, and not percutaneous transluminal angioplasty and stenting, according to a...
Source: Drugs.com - Pharma News - March 22, 2022 Category: Pharmaceuticals Source Type: news

NOAC Use Not Tied to ICH in Stroke Patients Treated With Alteplase
FRIDAY, Feb. 25, 2022 -- For patients with acute ischemic stroke receiving alteplase, use of non-vitamin K antagonist oral anticoagulants (NOACs) in the previous seven days is not associated with an increased risk for intracranial hemorrhage...
Source: Drugs.com - Pharma News - February 25, 2022 Category: Pharmaceuticals Source Type: news